SynthesisBMJ open ophthalmology2023

Systematic review of efficacy and meta-analysis of safety of ranibizumab biosimilars relative to reference ranibizumab anti-VEGF therapy for nAMD treatment.

Amin Hatamnejad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.